Misfolding caused by the pathogenic mutation G47R on the minor allele of alanine:glyoxylate aminotransferase and chaperoning activity of pyridoxine.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Biochimica et Biophysica Acta

• Publication date

  2015-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbapap.2015.07.002PMID 26149463
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Liver peroxisomal alanine:glyoxylate aminotransferase and the effects of mutations associated with Primary Hyperoxaluria Type I: An overview.

  2015cited by this paper
• The lower limits for protein stability and foldability in primary hyperoxaluria type I.

  2014cited by this paper
• Allele-specific Characterization of Alanine: Glyoxylate Aminotransferase Variants Associated with Primary Hyperoxaluria

  2014cited by this paper
• Vitamin B6 in primary hyperoxaluria I: first prospective trial after 40 years of practice.

  2014cited by this paper
• S81L and G170R mutations causing Primary Hyperoxaluria type I in homozygosis and heterozygosis: an example of positive interallelic complementation

  2014cited by this paper
• Multiple mechanisms of action of pyridoxine in primary hyperoxaluria type 1.

  2013cited by this paper
• The Role of Protein Denaturation Energetics and Molecular Chaperones in the Aggregation and Mistargeting of Mutants Causing Primary Hyperoxaluria Type I

  2013cited by this paper
• Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase.

  2013cited by this paper
• Tetrahydrobiopterin, its Mode of Action on Phenylalanine Hydroxylase, and Importance of Genotypes for Pharmacological Therapy of Phenylketonuria

  2013cited by this paper
• Crystal structure of the S187F variant of human liver alanine: Aminotransferase associated with primary hyperoxaluria type I and its functional implications

  2013cited by this paper
• Four of the Most Common Mutations in Primary Hyperoxaluria Type 1 Unmask the Cryptic Mitochondrial Targeting Sequence of Alanine:glyoxylate Aminotransferase Encoded by the Polymorphic Minor Allele*

  2012cited by this paper
• Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with Primary Hyperoxaluria Type I☆

  2012cited by this paper
• α-Galactosidase Aggregation Is a Determinant of Pharmacological Chaperone Efficacy on Fabry Disease Mutants*

  2012cited by this paper
• Rapid Profiling of Disease Alleles Using a Tunable Reporter of Protein Misfolding

  2012cited by this paper
• Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I

  2010cited by this paper
• Human liver peroxisomal alanine:glyoxylate aminotransferase: Different stability under chemical stress of the major allele, the minor allele, and its pathogenic G170R variant.

  2010cited by this paper
• Molecular Insight into the Synergism between the Minor Allele of Human Liver Peroxisomal Alanine:Glyoxylate Aminotransferase and the F152I Mutation*

  2009cited by this paper
• Partial trypsin digestion as an indicator of mis-folding of mutant alanine:glyoxylate aminotransferase and chaperone effects of specific ligands. Study of a spectrum of missense mutants.

  2008cited by this paper
• Human wild-type alanine:glyoxylate aminotransferase and its naturally occurring G82E variant: functional properties and physiological implications.

  2007cited by this paper
• Reconstruction of human hepatocyte glyoxylate metabolic pathways in stably transformed Chinese-hamster ovary cells.

  2006cited by this paper
• Consequences of missense mutations for dimerization and turnover of alanine:glyoxylate aminotransferase: study of a spectrum of mutations.

  2006cited by this paper
• Primary hyperoxaluria type 1: AGT mistargeting highlights the fundamental differences between the peroxisomal and mitochondrial protein import pathways.

  2006cited by this paper
• Molecular Etiology of Primary Hyperoxaluria Type 1: New Directions for Treatment

  2005cited by this paper
• Probing protein structure by limited proteolysis.

  2004cited by this paper
• Primary hyperoxaluria type 1 in the Canary Islands: A conformational disease due to I244T mutation in the P11L-containing alanine:glyoxylate aminotransferase

  2003cited by this paper
• Crystal structure of alanine:glyoxylate aminotransferase and the relationship between genotype and enzymatic phenotype in primary hyperoxaluria type 1.

  2003cited by this paper
• Functional Synergism between the Most Common Polymorphism in Human Alanine:Glyoxylate Aminotransferase and Four of the Most Common Disease-causing Mutations*

  2000cited by this paper
• Effect of N-terminal α-Helix Formation on the Dimerization and Intracellular Targeting of Alanine:Glyoxylate Aminotransferase*

  1999cited by this paper
• Determining subunit dissociation constants in natural and recombinant proteins.

  1999cited by this paper
• Mistargeting of peroxisomal L-alanine:glyoxylate aminotransferase to mitochondria in primary hyperoxaluria patients depends upon activation of a cryptic mitochondrial targeting sequence by a point mutation.

  1991cited by this paper
• An intronic duplication in the alanine: glyoxylate aminotransferase gene facilitates identification of mutations in compound heterozygote patients with primary hyperoxaluria type 1

  1991cited by this paper
• Identification of mutations associated with peroxisome-to-mitochondrion mistargeting of alanine/glyoxylate aminotransferase in primary hyperoxaluria type 1

  1990cited by this paper
• Peroxisomal alanine:glyoxylate aminotransferase and prenatal diagnosis of primary hyperoxaluria type 1.

  1986cited by this paper

• Unraveling the genetics of gulf war illness in diverse participants enrolled in the million veteran program.

  2025cites this paper
• A molecular journey on the pathogenesis of primary hyperoxaluria

  2024cites this paper
• Navigating the Evolving Landscape of Primary Hyperoxaluria: Traditional Management Defied by the Rise of Novel Molecular Drugs

  2024cites this paper
• Effect of the allelic background on the phenotype of primary hyperoxaluria type I

  2024cites this paper
• Muscle transcriptome analysis provides new insights into the growth gap between fast- and slow-growing Sinocyclocheilus grahami

  2023cites this paper
• Determinants of Kidney Failure in Primary Hyperoxaluria Type 1: Findings of the European Hyperoxaluria Consortium

  2023cites this paper
• Genetic assessment in primary hyperoxaluria: why it matters

  2022cites this paper
• Primary hyperoxaluria type 1: pathophysiology and genetics

  2022cites this paper
• Identification of Human Alanine–Glyoxylate Aminotransferase Ligands as Pharmacological Chaperones for Variants Associated with Primary Hyperoxaluria Type 1

  2022cites this paper
• Vitamin B6

  2020cites this paper
• Vitamin B6-dependent enzymes and disease

  2020cites this paper
• Genetic design of co-expressed Mesorhizobium loti carbonic anhydrase and chaperone GroELS to enhancing carbon dioxide sequestration.

  2020cites this paper
• Structural and functional insights on the roles of molecular chaperones in the mistargeting and aggregation phenotypes associated with primary hyperoxaluria type I.

  2019cites this paper
• Correlation between the molecular effects of mutations at the dimer interface of alanine–glyoxylate aminotransferase leading to primary hyperoxaluria type I and the cellular response to vitamin B6

  2018cites this paper
• Folding Defects Leading to Primary Hyperoxaluria.

  2018cites this paper
• Targeting Trafficking in Drug Development

  2018cites this paper
• Insight into the specificity and severity of pathogenic mechanisms associated with missense mutations through experimental and structural perturbation analyses

  2018cites this paper
• Molecular basis of primary hyperoxaluria: clues to innovative treatments

  2018cites this paper
• Biochemical Characterization of Aspergillus fumigatus AroH, a Putative Aromatic Amino Acid Aminotransferase

  2018cites this paper
• Treatment options in primary hyperoxaluria Type I

  2017cites this paper
• Electrostatic interactions drive native‐like aggregation of human alanine:glyoxylate aminostransferase

  2017cites this paper
• Two novel AGXT mutations identified in primary hyperoxaluria type-1 and distinct morphological and structural difference in kidney stones

  2016cites this paper
• Effects of interface mutations on the dimerization of alanine glyoxylate aminotransferase and implications in the mistargeting of the pathogenic variants F152I and I244T.

  2016cites this paper
• A Five-Gene Expression Signature Predicts Clinical Outcome of Ovarian Serous Cystadenocarcinoma

  2016cites this paper
• Natural and Unnatural Compounds Rescue Folding Defects of Human Alanine: Glyoxylate Aminotransferase Leading to Primary Hyperoxaluria Type I.

  2016cites this paper